Gentium announced the resignation of its Board Chair, President and CEO Dr. Laura Ferro, as well as four directors, Gigliola Bertoglio, Luca Breveglieri, Marco Codella and Andrea Zambon.
Novo Nordisk has appointed Per Falk, M.D., Ph.D., as vice president, North American clinical, medical and regulatory affairs.
Acorda Therapeutics has named Ruhi Kahn as vice president of business development.
Dynavax Technologies announced the retirement Deborah A. Smeltzer, vice president of operations and chief financial officer.
MDRNA has appointed James M. Karis to its board of directors.
Harold Baker has been named vice president of sales at ThermoGenesis.
Molecular Insight Pharmaceuticals has appointed Charles H. Abdalian, Jr. as vice president of finance, CFO.
Endo Pharmaceuticals announced the resignation of Chief Operating Officer Nancy Wysenski.
US Oncology announced the retirement of R. Dale Ross and appointment of Bruce Broussard as board chairman.
China Sky One Medical has elected William Wei Lee to its board of directors.
Cannabis Science has appointed Dr. Mitch Earleywine as the first member of its new scientific advisory board.
Dr. Julie Cherrington has joined Xenome's board of directors.
ICON announced the appointment of Dr. Alan Marion as vice president and medical director of the company's new clinical pharmacology unit.
Abaxis has named Brenton Hanlon to Vice President of North American medical sales and marketing.
Edmund Mickunas has been named vice president of regulatory for Advanced Cell Technology.
BioTime has appointed Walter Funk as vice president, stem cell research.
PsychoGenics has named David A. Lowe as chief scientific officer and executive vice president, research and development.
EGEN has promoted Jason Fewell, Ph.D., to vice president, preclinical research and development.
Cardinal Health has named George Barrett Chairman and CEO.
Omeros has named Stephen R. Murray, M.D., Ph.D. as vice president, clinical development.